Loading…

Genetic influence on vascular smooth muscle cell apoptosis

Vascular smooth muscle cell (VSMC) proliferation, migration, and apoptosis play important roles in many physiological processes and pathological conditions. To identify genetic influences on VSMC behavior, we measured these traits and undertook genome-wide association studies in primary umbilical ar...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2024-06, Vol.15 (6), p.402-12
Main Authors: McVey, David G., Andreadi, Catherine, Gong, Peng, Stanczyk, Paulina J., Solomon, Charles U., Turner, Lenka, Yan, Liu, Chen, Runji, Cao, Junjun, Nelson, Christopher P., Thompson, John R., Yu, Haojie, Webb, Tom R., Samani, Nilesh J., Ye, Shu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vascular smooth muscle cell (VSMC) proliferation, migration, and apoptosis play important roles in many physiological processes and pathological conditions. To identify genetic influences on VSMC behavior, we measured these traits and undertook genome-wide association studies in primary umbilical artery-derived VSMCs from >2000 individuals. Although there were no genome-wide significant associations for VSMC proliferation or migration, genetic variants at two genomic loci (7p15.3 and 7q32.3) showed highly significant associations with VSMC apoptosis ( P  = 1.95 × 10 −13 and P  = 7.47 × 10 −9 , respectively). The lead variant at the 7p51.3 locus was associated with increased expression of the GSDME and PALS2 genes in VSMCs. Knockdown of GSDME or PALS2 in VSMCs attenuated apoptotic cell death. A protein co-immunoprecipitation assay indicated that GSDME complexed with PALS2. PALS2 knockdown attenuated activated caspase-3 and GSDME fragmentation, whilst GSDME knockdown also reduced activated caspase-3. These findings provide new insights into the genetic regulation of VSMC apoptosis, with potential utility for therapeutic development.
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-024-06799-z